Core Laboratories Inc. reported a strong fourth quarter in 2025, with revenue reaching $138.3 million, a 7% increase year-over-year, surpassing guidance. Operating income stood at $15.8 million, and diluted EPS was $0.15. The company also reduced net debt by $1.2 million and repurchased 363,207 shares of common stock.